Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference96 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. Limitations of basing screening policies on screening trials: the US Preventive Services Task Force and Prostate Cancer Screening;Etzioni;Med Care,2013
3. Gleason 6 prostate cancer: translating biology into population health;Eggener;J Urol,2015
4. Increasing use of observation among men at low risk for prostate cancer mortality;Ritch;J Urol,2015
5. 20-year outcomes following conservative management of clinically localized prostate cancer;Albertsen;JAMA,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data;Cancers;2022-08-27
2. Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria;Urologia Internationalis;2022
3. Integration of magnetic resonance imaging into prostate cancer nomograms;Therapeutic Advances in Urology;2022-01
4. Active surveillance in prostate cancer management: where do we stand now?;Archives of Medical Science;2021-05-06
5. The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs;Nature Reviews Urology;2020-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3